Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe clinical trial record for NCT03071094 is now displayed, including its terminated status, study design, eligibility criteria, locations, and outcome measures.SummaryDifference47%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe 403 error page's footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check62 days agoChange DetectedAccess to the study record appears blocked by a 403 Forbidden page. The page content that previously displayed the study details is not accessible due to a server/permission restriction.SummaryDifference18%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.